Japan Insulin Drugs Delivery Devices Market Report by Type (Drug, Device), and Region 2024-2032

Japan Insulin Drugs Delivery Devices Market Report by Type (Drug, Device), and Region 2024-2032

Report Format: PDF+Excel | Report ID: SR112024A15120
Buy Now

Market Overview:

Japan insulin drugs delivery devices market size is projected to exhibit a growth rate (CAGR) of 2.34% during 2024-2032. The increasing incidences of diabetes in Japan coupled with the development of new insulin formulations and drugs that require specialized delivery devices are primarily driving the market.

Report Attribute
Key Statistics
Base Year
Forecast Years
Historical Years
Market Growth Rate (2024-2032) 2.34%

Insulin drugs delivery devices are essential tools for individuals suffering from diabetes, a chronic condition characterized by impaired insulin production or utilization. These devices enable precise and convenient administration of insulin, a hormone crucial for regulating blood sugar levels. One of the most notable advancements in insulin delivery is the insulin pen, which resembles a regular pen and allows for accurate dosing with a simple push of a button. Its discreet design and portability have made it a popular choice for type 1 and type 2 diabetics. Additionally, insulin pumps offer continuous subcutaneous insulin infusion, mimicking the natural insulin release in the body. These devices provide precise control over insulin dosage and can be programmed to match an individual's unique needs. Furthermore, the development of smart insulin delivery systems, which integrate with mobile apps and continuous glucose monitors, has further improved diabetes management. These devices enable real-time tracking of blood sugar levels and automated insulin adjustments, reducing the burden of constant monitoring and decision-making for patients.

Japan Insulin Drugs Delivery Devices Market Trends:

The insulin drugs delivery devices market in Japan is poised for significant growth, primarily due to several compelling drivers. Firstly, the rising prevalence of diabetes is a pivotal factor propelling market expansion. Moreover, the increasing awareness about diabetes management and the importance of timely insulin administration among patients and healthcare providers is contributing to the market's upward trajectory. Additionally, technological advancements in insulin delivery devices, such as the development of smart insulin pens and wearable insulin pumps, are driving patient convenience and adherence. Furthermore, the growing geriatric population, who are more susceptible to diabetes, is augmenting the demand for these devices. Apart from this, the escalating obesity rates and sedentary lifestyles in Japan are fueling the incidence of type 2 diabetes, further bolstering the insulin drugs delivery devices market. Additionally, the pursuit of personalized medicine and tailored insulin therapies is fostering innovation in device design and functionality. Moreover, favorable reimbursement policies for diabetes management products, which incentivize patients to adopt advanced insulin drugs delivery devices, are expected to drive the market in Japan during the forecast period.

Japan Insulin Drugs Delivery Devices Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the country level for 2024-2032. Our report has categorized the market based on type.

Type Insights:

Japan Insulin Drugs Delivery Devices Market Report

  • Drug                                             
    • Basal or Long-Acting Insulins          
      • Lantus (Insulin Glargine)
      • Levemir (Insulin Detemir)
      • Toujeo (Insulin Glargine)
      • Tresiba (Insulin Degludec)
      • Basaglar (Insulin Glargine)
    • Bolus or Fast-Acting Insulins
      • NovoRapid/Novolog (Insulin aspart)
      • Humalog (Insulin lispro)
      • Apidra (Insulin glulisine)
      • FIASP (Insulin aspart)
      • Admelog (Insulin lispro Sanofi)
    • Traditional Human Insulins
      • Novolin/Mixtard/Actrapid/Insulatard
      • Humulin
      • Insuman
    • Combination Insulins        
      • NovoMix (Biphasic Insulin aspart)
      • Ryzodeg (Insulin degludec and Insulin aspart)
      • Xultophy (Insulin degludec and Liraglutide)
      • Soliqua/Suliqua (Insulin glargine and Lixisenatide)
    • Biosimilar Insulins             
      • Insulin Glargine Biosimilars
      • Human Insulin Biosimilars
  • Device                      
    • Insulin Pumps                  
      • Insulin Pump Devices
      • Insulin Pump Reservoirs
      • Insulin Infusion sets
    • Insulin Pens                   
      • Cartridges in reusable pens
      • Disposable insulin pens
    • Insulin Syringes                 
    • Insulin Jet Injectors

The report has provided a detailed breakup and analysis of the market based on the type. This includes drug [basal or long-acting insulins (lantus (insulin glargine), levemir (insulin detemir), toujeo (insulin glargine), tresiba (insulin degludec), and basaglar (insulin glargine)), bolus or fast-acting insulins (novorapid/novolog (insulin aspart), humalog (insulin lispro), apidra (insulin glulisine), fiasp (insulin aspart), and admelog (insulin lispro sanofi)), traditional human insulins (novolin/mixtard/actrapid/insulatard, humulin, and insuman), combination insulins (novomix (biphasic insulin aspart), ryzodeg (insulin degludec and insulin aspart), xultophy (insulin degludec and liraglutide), and soliqua/suliqua (insulin glargine and lixisenatide)), and biosimilar insulins (insulin glargine biosimilars and human insulin biosimilars)] and device [insulin pumps (insulin pump devices, insulin pump reservoirs, and insulin infusion sets), insulin pens (cartridges in reusable pens and disposable insulin pens), insulin syringes, and insulin jet injectors].

Regional Insights:

Japan Insulin Drugs Delivery Devices Market Report

  • Kanto Region
  • Kansai/Kinki Region
  • Central/ Chubu Region
  • Kyushu-Okinawa Region
  • Tohoku Region
  • Chugoku Region
  • Hokkaido Region
  • Shikoku Region

The report has also provided a comprehensive analysis of all the major regional markets, which include Kanto Region, Kansai/Kinki Region, Central/ Chubu Region, Kyushu-Okinawa Region, Tohoku Region, Chugoku Region, Hokkaido Region, and Shikoku Region.

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Japan Insulin Drugs Delivery Devices Market Report Coverage:

Report Features Details
Base Year of the Analysis 2023
 Historical Period 2018-2023
Forecast Period 2024-2032
Units US$ Million
Scope of the Report Exploration of Historical and Forecast Trends, Industry Catalysts and Challenges, Segment-Wise Historical and Predictive Market Assessment: 
  • Type
  • Region 
Types Covered
  • Drug: Basal or Long-Acting Insulins, Bolus or Fast-Acting Insulins, Traditional Human Insulins, Combination Insulins, Biosimilar Insulins
  • Device: Insulin Pumps, Insulin Pens, Insulin Syringes, Insulin Jet Injectors
Regions Covered Kanto Region, Kansai/Kinki Region, Central/ Chubu Region, Kyushu-Okinawa Region, Tohoku Region, Chugoku Region, Hokkaido Region, Shikoku Region
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 3699
Five User License: US$ 4699
Corporate License: US$ 5699
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

Key Questions Answered in This Report:

  • How has the Japan insulin drugs delivery devices market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the Japan insulin drugs delivery devices market?
  • What is the breakup of the Japan insulin drugs delivery devices market on the basis of type?
  • What are the various stages in the value chain of the Japan insulin drugs delivery devices market? 
  • What are the key driving factors and challenges in the Japan insulin drugs delivery devices?
  • What is the structure of the Japan insulin drugs delivery devices market and who are the key players?
  • What is the degree of competition in the Japan insulin drugs delivery devices market?

Key Benefits for Stakeholders:

  • IMARC’s industry report offers a comprehensive quantitative analysis of various market segments, historical and current market trends, market forecasts, and dynamics of the Japan insulin drugs delivery devices market from 2018-2032.
  • The research report provides the latest information on the market drivers, challenges, and opportunities in the Japan insulin drugs delivery devices market.
  • Porter's five forces analysis assist stakeholders in assessing the impact of new entrants, competitive rivalry, supplier power, buyer power, and the threat of substitution. It helps stakeholders to analyze the level of competition within the Japan insulin drugs delivery devices industry and its attractiveness.
  • Competitive landscape allows stakeholders to understand their competitive environment and provides an insight into the current positions of key players in the market. 

Need more help?

  • Speak to our experienced analysts for insights on the current market scenarios.
  • Include additional segments and countries to customize the report as per your requirement.
  • Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  • For further assistance, please connect with our analysts.
Japan Insulin Drugs Delivery Devices Market Report by Type (Drug, Device), and Region 2024-2032
Purchase options

Benefits of Customization

Personalize this research

Triangulate with your data

Get data as per your format and definition

Gain a deeper dive into a specific application, geography, customer, or competitor

Any level of personalization

Get in Touch With Us

Phone: +1-631-791-1145


Phone: +91-120-433-0800


Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials

Aktive Services

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

Read More
Greenfish S.A.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

Read More
Colruyt Group

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Read More

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

Read More
Zee Media Corp. Ltd.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Read More
Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

Read More
Sumitomo Corporation

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

Read More
Hameln Rds

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

Read More
Quality Consultants BV

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

Read More
TATA Advanced Systems Limited

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

Read More

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

Read More